Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.

Molecular cancer - 8 Mar 2021

Huang Xing, Tang Tianyu, Zhang Gang, Liang Tingbo

Abstract excerpt

BACKGROUND: The mRNA-based cancer vaccine has been considered a promising strategy and the next hotspot in cancer immunotherapy. However, its application on cholangiocarcinoma remains largely uncharacterized. This study aimed to identify potential antigens of cholangiocarcinoma for development of anti-cholangiocarcinoma mRNA vaccine, and determine immune subtypes of cholangiocarcinoma for selection of suitable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigen-Presenting Cells
Share to Antigens, Neoplasm
Share to Bile Duct Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cancer Vaccines

Share to Cholangiocarcinoma

Share to Immunity

Share to Immunomodulation

Share to Immunotherapy

Source

Open in PubMed Open full text

Identifiers

PMID: 33685460
DOI: 10.1186/s12943-021-01342-6
PMCID: PMC7938044

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development.PMID 33685460Read ↗

Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune SubtypeSemantic proximity Read ↗

Dissecting Novel Tumor Antigens and Immune Subtypes Guided mRNA Vaccine Development for HBV Related-Hepatocellular CarcinomaSemantic proximity Read ↗

Immunogenomics of cholangiocarcinomaSemantic proximity Read ↗

Based on the identification of tumor antigens and immune subtypes in renal clear cell carcinoma for mRNA vaccine developmentSemantic proximity Read ↗

Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine.Semantic proximity Read ↗

The Immune–Genomics of Cholangiocarcinoma: A Biological Footprint to Develop Novel ImmunotherapiesSemantic proximity Read ↗

Investigation of transcriptional and immunological disparities among patient groups with varied prognostic risk factors in cholangiocarcinoma.Semantic proximity Read ↗

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.Semantic proximity Read ↗

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA VaccinationSemantic proximity Read ↗

PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing TechnologySemantic proximity Read ↗

Identification of Transcriptional Regulators of Immune Evasion across Cancers: An Alternative Immunotherapeutic Strategy for CholangiocarcinomaSemantic proximity Read ↗

Proteogenomic characterization reveals antitumor mechanisms of intrahepatic cholangiocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.